Cargando…
The Construction of Chimeric T-Cell Receptor with Spacer Base of Modeling Study of VHH and MUC1 Interaction
Adaptive cell immunotherapy with the use of chimeric receptors leads to the best and most specific response against tumors. Chimeric receptors consist of a signaling fragment, extracellular spacer, costimulating domain, and an antibody. Antibodies cause immunogenicity; therefore, VHH is a good repla...
Autores principales: | Pirooznia, Nazanin, Hasannia, Sadegh, Taghdir, Majid, Rahbarizadeh, Fatemeh, Eskandani, Morteza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160013/ https://www.ncbi.nlm.nih.gov/pubmed/21869862 http://dx.doi.org/10.1155/2011/578128 |
Ejemplares similares
-
A VHH-Based Anti-MUC1 Chimeric Antigen Receptor for
Specific Retargeting of Human Primary T Cells to
MUC1-Positive Cancer Cells
por: Rajabzadeh, Alireza, et al.
Publicado: (2021) -
T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts
por: Nasiri, Fatemeh, et al.
Publicado: (2023) -
OXIDATIVE STRESS LEVEL AND TYROSINASE ACTIVITY IN VITILIGO PATIENTS
por: Eskandani, M, et al.
Publicado: (2010) -
ASSESSMENT OF MC1R AND α-MSH GENE SEQUENCES IN IRANIAN VITILIGO PATIENTS
por: Eskandani, M, et al.
Publicado: (2010) -
Encapsulation of Alpha-1 antitrypsin in PLGA nanoparticles: In Vitro characterization as an effective aerosol formulation in pulmonary diseases
por: Pirooznia, Nazanin, et al.
Publicado: (2012)